As of 2026-04-03, the Fair Value of Longboard Pharmaceuticals Inc (LBPH) is -9.78 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 59.98 USD, the upside of Longboard Pharmaceuticals Inc is -116.30%.
With the market price of 59.98 USD and our fair value calculation, Longboard Pharmaceuticals Inc (LBPH) is not a good investment. Investing in LBPH stocks now will result in a potential loss of 116.30%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | - | 5Y Avg | |
| Net income | -27.80 | -43.95 | -54.42 | - | -42.06 | |
| YoY growth | -93.06% | -58.09% | -23.83% | - | -58.33% | |
| Market Cap (mil) | 2,342.22 |
| P/E | |
| Forward P/E |
| EPS | -1.96 |
| Avg earnings growth rate | -58.33% |
| TTM earnings | -76.34 |